The levels of C3a were clearly elevated (2552±1292 ng ml−1) in the ovarian cancer patient AF samples, as compared to values present in normal sera (26–146 ng ml−1) or in nonmalignant AF samples (240 and 1200 ng ml−1). This evidence concerns the gene C3 and atrial fibrillation.